Patients dying in cancer drugs wait: MA

Australian cancer patients don’t have time to wait for access to new cancer drugs, says Medicines Australia. In its submission to the Senate Inquiry into the availability of new, innovative and specialist cancer drugs in Australia, Medicines Australia says the time lag between the Therapeutic Goods Administration’s approval and listing on the PBS is costing